within subject standard deviation in fully replicate design if carry over effect is present [General Sta­tis­tics]

posted by dshah  – India, 2023-06-14 12:37 (546 d 01:22 ago) – Posting: # 23591
Views: 2,186

Hello Ankit!

As per PSG, the recommendation is parallel study.

[image]

❝ So how to calculate Swr when unequal carryover effect is present in full replicate study design?


Moreover, the study population is patient and you can not stop the treatment. So why fully replicate CO study?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,665 registered users;
43 visitors (0 registered, 43 guests [including 10 identified bots]).
Forum time: 13:00 CET (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5